Group One Trading
CRDL icon

Group One Trading’s Cardiol Therapeutics CRDL Stock Holding History

Group One Trading’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$608 Hold
366
– – ﹤0.01% 7231
2026
Q2 		$388 Buy
+366
New +$463 ﹤0.01% 7330
2025
Q4 		– Sell
-1,534
Closed -$1.61K – 8269
2025
Q3 		$1.64K Sell
1,534
-6,179
-80% -$7.5K ﹤0.01% 7956
2025
Q2 		$10.5K Sell
7,713
-733
-9% -$853 ﹤0.01% 6689
2025
Q1 		$8.19K Buy
8,446
+3,139
+59% +$3.85K ﹤0.01% 6390
2024
Q4 		$6.79K Sell
5,307
-19,533
-79% -$32.9K ﹤0.01% 6288
2024
Q3 		$49.2K Sell
24,840
-3,452
-12% -$7.16K ﹤0.01% 4661
2024
Q2 		$57.2K Buy
28,292
+24,625
+672% +$52.3K ﹤0.01% 4423
2024
Q1 		$6.64K Hold
3,667
– – ﹤0.01% 6071
2023
Q4 		$3.08K Buy
3,667
+2,000
+120% +$1.7K ﹤0.01% 6689
2023
Q3 		$1.53K Buy
1,667
+1,666
+166,600% +$1.59K ﹤0.01% 7120
2023
Q2 		$1 Hold
1
– – ﹤0.01% 7572
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7314
2022
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 7127

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return
Tejara Capital
Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $200B AUM 30.19% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Birchview Capital
Birchview Capital Burlington, Vermont $173M AUM 89.27% 1-Year Est. Return

Group One Trading's CRDL Position: Q3 2026 in Review

Group One Trading held its Cardiol Therapeutics (CRDL) position steady in Q3 2026 at 366 shares worth $608. The position accounts for ﹤0.01% of the portfolio, ranked #7231.

Group One Trading first reported a position in CRDL in Q4 2022 and has held it in 14 quarters since. The position peaked at $57.2K in Q2 2024. 43 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • Group One Trading held 366 shares of Cardiol Therapeutics worth $608 as of Q3 2026.
  • Group One Trading left its Cardiol Therapeutics share count unchanged in Q3 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7231 holding.
  • Group One Trading first reported a position in Cardiol Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • Group One Trading's Cardiol Therapeutics position peaked at $57.2K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.